Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
- 1 July 2002
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 13 (7) , 1036-1043
- https://doi.org/10.1093/annonc/mdf252
Abstract
F1000Prime Recommended Article: Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites.Keywords
This publication has 19 references indexed in Scilit:
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine, 2001
- Breast Cancer in the 21st Century: Neu Opportunities and Neu ChallengesLaboratory Investigation, 2001
- Breast cancer preventionEuropean Journal Of Cancer, 2000
- Genetic alterations in breast cancerGenes, Chromosomes and Cancer, 1995
- Clonal heterogeneity in breast cancer: Karyotypic comparisons of multiple intra—and extra—tumorous samples from 3 patientsInternational Journal of Cancer, 1995
- Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroupsGenes, Chromosomes and Cancer, 1995
- Stability of HER-2/neu Expression Over Time and at Multiple Metastatic SitesJNCI Journal of the National Cancer Institute, 1993
- Clonal chromosome abnormalities in human breast carcinomas II. Thirty‐four cases with metastatic diseaseGenes, Chromosomes and Cancer, 1993
- Tumor Cell SocietiesJNCI Journal of the National Cancer Institute, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987